Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146,467,184
-
Total 13F shares
-
86,773,703
-
Share change
-
+478,756
-
Total reported value
-
$6,755,702,862
-
Put/Call ratio
-
13%
-
Price per share
-
$77.87
-
Number of holders
-
335
-
Value change
-
+$42,211,359
-
Number of buys
-
149
-
Number of sells
-
179
Institutional Holders of RESMED INC - Common Stock (RMD) as of Q2 2017
As of 30 Jun 2017,
RESMED INC - Common Stock (RMD) was held by
335 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
86,773,703 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Capital World Investors, FMR LLC, BAILLIE GIFFORD & CO, STATE STREET CORP, Bank of New York Mellon Corp, COMMONWEALTH BANK OF AUSTRALIA, NORTHERN TRUST CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
336
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.